Acadia Pharmaceuticals Inc. · NASDAQ:ACAD
Vanguard Portfolio Management LLC reported a 5.15% stake in Acadia Pharmaceuticals Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 28, 2026
Vanguard Portfolio Management LLC reported a 5.15% stake in Acadia Pharmaceuticals Inc., 8,781,007 shares, as a passive investor on Mar 31, 2026. Filed Apr 28, 2026 (Schedule 13G).
- Stake
- 5.15%
- Shares
- 8,781,007
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Portfolio Management | 5.15% | 8,781,007 |
Source
Related
- Acadia Pharmaceuticals Inc.
- Vanguard Portfolio Management LLC
- Acadia Pharmaceuticals Inc. shareholders
- Form 4 · Schneyer Mark C. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Thompson Elizabeth H.Z. · Jul 31, 2026
- Form 4 · Kihara James · Jun 29, 2026
- Form 4 · Baker Brothers Life Sciences LP · Jun 2, 2026